Health / Medical Topics

    Unfavorable Shimada Classification

    Patients of any age with stroma-poor tumors, undifferentiated or differentiated neuroblasts, and a mitosis-karyorrhexis index of more than 200; or patients older than 18 months with stroma-poor tumors, undifferentiated neuroblasts, and a mitosis-karyorrhexis index of 100-200; or patients older than 60 months with stroma-poor tumors, differentiated neuroblasts, and a mitosis-karyorrhexis index of less than 100. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    Expressing something as negative, undesired or adverse.
    Issue associated with the use of a medical device for therapeutic purposes.
    A coded value specifying the rationale for why an unanticipated activity or event occurred.
    Any adverse event associated with a medical product or procedure that has not been previously observed, whether or not the event was…
    Unable to be evaluated.
    An overall level of substantial worsening in non-target disease that is of a magnitude that, even in the presence of SD or…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact